help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on June 29, 2006
Endocrinology, doi:10.1210/en.2006-0563
A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/10/4831    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, E. C.
Right arrow Articles by Katzenellenbogen, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, E. C.
Right arrow Articles by Katzenellenbogen, B. S.

Submitted on April 28, 2006
Accepted on June 19, 2006

Impact of Estrogen Receptor Beta on Gene Networks Regulated by Estrogen Receptor Alpha in Breast Cancer Cells

Edmund C. Chang, Jonna Frasor, Barry Komm, and Benita S. Katzenellenbogen*

Departments of Molecular and Integrative Physiology, and Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801; Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, PA, 19426

* To whom correspondence should be addressed. E-mail: katzenel{at}uiuc.edu.

Two subtypes of the estrogen receptor, ERalpha and ERbeta, mediate the actions of estrogens, and although seventy percent of human breast cancers express ERbeta along with ERalpha, little is known about the possible co-modulatory effects of these two ERs. To investigate this, we have used adenoviral gene delivery to produce human breast cancer (MCF-7) cells expressing different levels of ERbeta, along with their endogenous ERalpha, and have examined the effects of ERbeta and receptor occupancy, using ER subtype selective ligands, on genome-wide gene expression by microarray and pathway network analysis. ERbeta had diverse effects on gene expression, enhancing or counteracting ERalpha regulation for distinct subsets of estrogen target genes. Strikingly, ERbeta in the absence of estradiol (E2), elicited the stimulation or suppression of many genes that were normally only regulated by ERalpha with E2. In addition, ERbeta plus E2 elicited the expression of a unique group of genes that were not regulated by ERalpha plus E2 alone. The expression of genes in many functional categories were modulated by ERbeta, with the greatest numbers associated with transcription factors and signal transduction pathways. Regulation of multiple components in the TGF beta and semaphorin pathways, and of genes controlling cell cycle progression and apoptosis, may contribute to the suppression of cell proliferation observed with ERbeta. Our observations suggest that the relative levels of ERbeta and ERalpha in breast cancers are likely to impact cell proliferation and the activities of diverse signaling pathways and their response to ER ligands and endocrine therapies.
Key words: Estrogen Receptors • Breast Cancer • Gene Transcriptional Profiling • Proliferation




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Y. Dai, M. J. Chalmers, J. Bruning, K. S. Bramlett, H. E. Osborne, C. Montrose-Rafizadeh, R. J. Barr, Y. Wang, M. Wang, T. P. Burris, et al.
Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method
PNAS, May 20, 2008; 105(20): 7171 - 7176.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
E. C. Chang, T. H. Charn, S.-H. Park, W. G. Helferich, B. Komm, J. A. Katzenellenbogen, and B. S. Katzenellenbogen
Estrogen Receptors {alpha} and {beta} as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding
Mol. Endocrinol., May 1, 2008; 22(5): 1032 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Liu, H. Gao, T. T. Marstrand, A. Strom, E. Valen, A. Sandelin, J.-A. Gustafsson, and K. Dahlman-Wright
The genome landscape of ER{alpha}- and ER{beta}-binding DNA regions
PNAS, February 19, 2008; 105(7): 2604 - 2609.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Carreras, S. Turner, V. Paharkova-Vatchkova, A. Mao, C. Dascher, and S. Kovats
Estradiol Acts Directly on Bone Marrow Myeloid Progenitors to Differentially Regulate GM-CSF or Flt3 Ligand-Mediated Dendritic Cell Differentiation
J. Immunol., January 15, 2008; 180(2): 727 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. D. Stender, J. Frasor, B. Komm, K. C. N. Chang, W. L. Kraus, and B. S. Katzenellenbogen
Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation
Mol. Endocrinol., September 1, 2007; 21(9): 2112 - 2123.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Savolainen, T. Pakarainen, I. Huhtaniemi, M. Poutanen, and S. Makela
Delay of Postnatal Maturation Sensitizes the Mouse Prostate to Testosterone-Induced Pronounced Hyperplasia: Protective Role of Estrogen Receptor-{beta}
Am. J. Pathol., September 1, 2007; 171(3): 1013 - 1022.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
Y. Su, F. A. Simmen, R. Xiao, and R. C. M. Simmen
Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors
Physiol Genomics, June 19, 2007; 30(1): 8 - 16.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society